Shinko Asset Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Shinko Asset Management Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$55K	Hold	631	–	–	﹤0.01%	504
2016 Q2	$54K	Sell	631 -54	-8%	-$4.67K	﹤0.01%	505
2016 Q1	$54K	Hold	685	–	–	﹤0.01%	501
2015 Q4	$86K	Hold	685	–	–	﹤0.01%	435
2015 Q3	$71K	Sell	685 -62	-8%	-$7.96K	﹤0.01%	467
2015 Q2	$92K	Hold	747	–	–	﹤0.01%	353
2015 Q1	$88K	Sell	747 -53	-7%	-$6.35K	﹤0.01%	306
2014 Q4	$95K	Sell	800 -100	-11%	-$11.3K	﹤0.01%	300
2014 Q3	$101K	Sell	900 -100	-10%	-$9.52K	﹤0.01%	308
2014 Q2	$95K	Hold	1,000	–	–	﹤0.01%	330
2014 Q1	$71K	Hold	1,000	–	–	﹤0.01%	376
2013 Q4	$74K	Hold	1,000	–	–	﹤0.01%	374
2013 Q3	$76K	Sell	1,000 -100	-9%	-$7.96K	﹤0.01%	362
2013 Q2	$88K	Buy	+1,100	New	+$81K	﹤0.01%	328

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Shinko Asset Management Company's VRTX Position: Q3 2016 in Review

Shinko Asset Management Company held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2016 at 631 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Shinko Asset Management Company first reported a position in VRTX in Q2 2013 and has held it in 14 quarters since. The position peaked at $101K in Q3 2014. 490 funds tracked by Wall St. Rank hold VRTX as of Q3 2016.

Shinko Asset Management Company held 631 shares of Vertex Pharmaceuticals worth $55K as of Q3 2016.
Shinko Asset Management Company left its Vertex Pharmaceuticals share count unchanged in Q3 2016.
Vertex Pharmaceuticals made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #504 holding.
Shinko Asset Management Company first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Shinko Asset Management Company's Vertex Pharmaceuticals position peaked at $101K in Q3 2014.
490 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.